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Abstract
Background: Tourette syndrome (TS) is a disorder characterized by childhood onset of motor and phonic tics, often with improvement of tic symptoms by young
adult years. The temporal course of tics and commonly comorbid behavioral symptoms is still not well characterized.
Methods: In order to clarify the time course of tics and comorbid attention deficit hyperactivity disorder (ADHD) or obsessive compulsive disorder (OCD) in TS,
we administered a brief survey regarding the course of symptoms at a single point in time to 53 TS patients aged 13–31 years.
Results: Mean age (¡SD) at symptom onset was 7.9 (¡3.6) years for tics, 7.9 (¡3.5) for ADHD, and 9.2 (¡5.0) for OCD. Age at peak symptom severity was 12.3
(¡4.6) years for tics, 10.8 (¡3.8) for ADHD, and 12.6 (¡5.5) for OCD. Tics, ADHD, and OCD were reported to be no longer present in 32.0%, 22.8%, and
21.0% of subjects, respectively. Decline in symptom severity began at age 14.7 (¡3.7) years for tics, 13.9 (¡2.9) for ADHD, and 15.1 (¡5.0) for OCD. Remission
of symptoms occurred at age 17.4 (¡3.8) years for tics, 17.4 (¡1.3) for ADHD, and 15.6 (¡2.3) for OCD.
Discussion: Our data confirm and expand previously reported TS spectrum symptom milestones and may guide design of future research aimed at improving the
course of TS.
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Introduction
Tourette syndrome (TS) is defined by childhood onset of multiple
motor and vocal tics lasting more than one year.
1 Tics, attention deficit
hyperactivity disorder (ADHD), and obsessive compulsive symptoms
(OCS), comorbid in the majority of TS patients, constitute a TS
neuropsychiatric spectrum and this combination is commonly known
as the TS ‘‘clinical triad.’’
2 The mean age at onset of tics has been
reported to be 6.4 years in patients with TS.
3 While the severity of
tics typically waxes and wanes over time, many patients appear to
experience a lessening of symptoms as they grow into adulthood. A
peak in tic severity has been reported to occur between the ages of 10
and 13 years;
4,5 significant reduction in tic severity has been reported
to begin at a mean age of 16 years, and between 26% and 50% of
patients have been described as being essentially free of tics by early
adulthood.
4,6,7 While substantial reductions in tic severity have been
called ‘‘tic remissions,’’ many TS patients who report that their tics are
in remission still have tics that are appreciated by an expert
8 or recur
during times of psychosocial stress.
9 There are also reports of tics
observed in individuals older than age 60, even after being reportedly
absent for more than 40 years.
10,11 Little information is available
regarding the natural course of the other components of the TS triad,
comorbid ADHD, and OCD. In order to guide development of
therapies aimed at hastening or increasing the likelihood of remission,
we conducted a patient survey to gather more information on the
temporal course of the full TS triad.
Methods
The University of Rochester Research Subject Review Board
approved the study protocol and all subjects provided informed
consent. Eligible subjects had a diagnosis of TS and were 13–35 years
of age at the time of the survey. From August 2008 to January 2009,
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University of Rochester TS Clinic and from billing records of the clinic
to identify other patients who would be adolescents or adults at the
time of the survey. Selected subjects had been diagnosed by our
clinicians using the Diagnostic and Statistical Manual of Psychiatry,
4th Edition as having TS (Tourette’s disorder), OCD, or ADHD.
There were no exclusion criteria. Severity of symptoms was not
considered in subject selection. Information on medication treatment
over time was not gathered. Subjects were interviewed directly either
in-person (53%) or by telephone (47%) (for adolescents, a parent also
joined the interview) using a standard questionnaire that included four
main questions about tics, ADHD, and OCD: 1) age at onset, 2) age at
peak severity, 3) age at which symptoms began to lessen, and 4) age at
which symptoms were considered to be absent. The survey was
conducted by a trained graduate student (L.A.R.) and subjects were
informed about the purpose of the study, namely to obtain information
about the course of their symptoms over time. In order to try to limit
recall errors, the student also reviewed each subject’s clinic records and
any discrepancies were reviewed by calling the subject back. We used
descriptive statistics to determine the frequency and the mean ages of
occurrence for each of these milestones and the Pearson product–
moment test to measure the strength of the relationship between these
variables. An analysis of variance (ANOVA) was used to examine time
course variables when factored by gender.
Results
The TS clinic included a total of 63 TS patients between the ages of
13 and 35 years. Fifty-three (84%) participants (79.2% male, mean age
19.4 [¡5.3] years) completed the survey. Among the participants,
68% had been diagnosed with ADHD and 71.62% with OCD. Mean
age (¡SD) at symptom onset was 7.9 (¡3.6) for tics, 7.9 (¡3.5) for
ADHD, and 9.2 (¡5.0) for OCD. Age at peak symptom severity was
12.3 (¡4.6) for tics, 10.8 (¡3.8) for ADHD, and 12.6 (¡5.5) years for
OCD; 83.0% reported that their tics had lessened over time, and tics
were reported to have stopped in 32.0%. Comorbid ADHD or OCD
was reported to have resolved in 22.8% and 21.0% of subjects,
respectively. Decline in symptom severity began at age 14.7 (¡3.7) for
tics, 13.9 (¡2.9) for ADHD, and 15.1 (¡5.0) for OCD. Resolution of
symptoms occurred at age 17.4 (¡ 3.8) for tics, 17.4 (¡1.3) for
ADHD, and 15.6 (¡2.3) for OCD (Table 1.)
A Pearson product–moment test found significant correlations
between several of the variables, and these are summarized in Table 2
(Table 2). Significance was found for age at tic onset and age at peak
tic severity, age at tic onset and age at which tics began to lessen, and
age at peak tic severity and age at which tics began to lessen (Table 2).
Age at tic onset was also found to correlate with the age at OCD
symptom onset, and OCD symptom onset correlated with ADHD
symptom onset. The age at which tics were at their worst related to the
age at which OCD and ADHD symptoms were peaking as well, and
correlations were found between OCD peak symptom age and ADHD
peak symptom age. Additionally, statistically significant relationships
were found between the age at tic lessening and both age at OCD
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Tics
Began
Age When
Tics Were
Worst
Age When
Tics
Lessened
OC
Symptoms
Began
ADHD
Symptoms
Began
ADHD
Symptoms
Worst
OC
Symptoms
Worst
OC
Symptoms
Lessened
ADHD
Symptoms
Lessened
Tics began Pearson
correlation
1 0.625** 0.444** 0.450** 0.270 0.260 0.455
** 0.255 0.228
Sig. (2-tailed) 0.000 0.003 0.005 0.117 0.157 0.009 0.209 0.320
Age when tics
were worst
Correlation
Pearson
correlation
0.625** 1 0.776** 0.282 0.013 0.361
* 0.635** 0.233 0.073
Sig. (2-tailed) 0.000 0.000 0.086 0.940 0.046 0.000 0.252 0.753
Age when tics
lessened
Pearson
correlation
0.444
** 0.776
** 1 0.326 0.169 0.556
** 0.520
** 0.541
** 0.653
**
Sig. (2-tailed) 0.003 0.000 0.073 0.363 0.003 0.005 0.006 0.002
OC symptoms
began
Pearson
correlation
0.450
** 0.282 0.326 1 0.607
** 0.479
* 0.719
** 0.672
** 0.375
Sig. (2-tailed) 0.005 0.086 0.073 0.001 0.013 0.000 0.000 0.125
ADHD symptoms
began
Pearson
correlation
0.270 0.013 0.169 0.607
** 1 0.612
** 0.276 0.468
* 0.611
**
Sig. (2-tailed) 0.117 0.940 0.363 0.001 0.000 0.203 0.043 0.004
ADHD symptoms
worst
Pearson
correlation
0.260 0.361
* 0.556
** 0.479
* 0.612
** 1 0.611
** 0.679
** 0.826
**
Sig. (2-tailed) 0.157 0.046 0.003 0.013 0.000 0.002 0.002 0.000
OC symptoms
worst
Pearson
correlation
0.455
**
0.635
**
0.520
**
0.719
** 0.276
0.611
** 1 0.927
** 0.472
Sig. (2-tailed) 0.009 0.000 0.005 0.000 0.203 0.002 0.000 0.076
OC symptoms
lessened
Pearson
correlation
0.255 0.233
0.541
**
0.672
**
0.468
*
0.679
**
0.927
** 1 0.710
**
Sig. (2-tailed) 0.209 0.252 0.006 0.000 0.043 0.002 0.000 0.004
ADHD symptoms
lessened
Pearson
correlation
0.228 0.073 0.653
** 0.375 0.611
** 0.826
** 0.472 0.710
** 1
Sig. (2-tailed) 0.320 0.753 0.002 0.125 0.004 0.000 0.076 0.004
ADHD, Attention Deficit Hyperactivity Disorder; OC, Obsessive Compulsive.
*Correlation is significant at the 0.05 level (2-tailed).
**Correlation is significant at the 0.01 level (2-tailed).
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3symptom lessening and age at ADHD symptom lessening, as well as
between OCD and ADHD symptom lessening (Table 2).
Only 63.6% of the female subjects experienced a lessening of their
symptoms compared to 88% of the males, and just one female (9.0%)
reported that her tics had stopped (male538.0%). Significant gender
differences were found for the categories of age at tic onset (F54.84,
p50.032), age at which tics were at their peak (F58.77, p50.005), and
age at which tics began to lessen (F56.47, p50.015), with males
having younger ages at all points.
Discussion
The results of this survey study provide further data to define the
expected temporal course for the symptoms of TS. An identical rate of
tic remission (32%) was reported in a recent longitudinal study.
7 That
study included a younger age group (16–23 years) of subjects at the time
of follow-up, suggesting that it might be an underestimate since longer
follow-up into adulthood might have yielded more subjects with
remission. The current study adds to the knowledge of tic evolution
by incorporating age-specific information about the timing of tic
remission. This study is also the first to systematically gather time course
data regarding the full TS clinical triad by including the common
comorbidities ADHD and OCD. The results for mean age at tic onset
(7.9 years) and peak tic severity (12.3 years) fall within previously
reported ranges (6–8 and 10–13 years, respectively.)
3–8 The reported
mean age at onset of ADHD (7.9 years) is older than standard diagnostic
criteria for the condition (symptom onset before age 7 in DSM-IV).
1
This could reflect recall error or bias, as possibly evidenced by the fact
that reported ages at onset for ADHD and tics were essentially identical.
The mean age at tic improvement (14.8 years) is also similar to the
previously reported 16 years.
6 We found that 22% of subjects with TS
and ADHD reported remission of ADHD. Previous studies on the
temporal course of ADHD in general (not comorbid with TS) differed
from ours in that they did not use self-reports. Symptom improvement
(defined as no longer meeting full diagnostic criteria for ADHD) was
reported at 60–70% for young adults.
12,13 One previous longitudinal
study (mean age at enrollment 12 years, mean follow-up interval 9 years)
of individuals with OCD (and TS, as well as ADHD, comorbidity
rates540%) found that 44% had minimal symptoms and were classified
as having experienced remission.
14 This study utilized a Yale Brown
Obsessive Compulsive Score of less than 8 as the cut-off for defining
remission. Our finding of a lower 21% rate of TS-associated OCD
symptom resolution may reflect differences in methodology.
Although the number of female subjects in our study was small, our
analyses suggest a difference between genders with respect to age at tic
onset, age at peak tic severity, and age at which tics began to lessen,
with male subjects having younger ages at all points. The proportion of
females in our sample (21%) is comparable to that reported in a meta-
analysis of larger TS population studies,
15 but further data are needed
to clarify differences in temporal course or long-term outcome between
the genders.
There are potential limitations to our study. Being retrospective,
there may have been inaccuracies in recall by the subjects. In order to
lessen this potential confound, we chose subjects in the age range of
13–35 so they would not be too many years beyond the times of their
milestones. Also, to limit recall bias subject responses were verified
with information in our medical records. Given that some of the
participants had undergone new evaluation for tics as adults, our
observed rate of reported tic remission may have been subject to
referral bias. We did not retain data about the patients who declined to
participate, so it is not possible to rule out some degree of selection
bias. Investigator bias related to an expectation of finding tic, ADHD
and OCD peaking and remission may have been introduced by the
framing of the questions used in our survey. This may have resulted in
unintended leading questions or conferring excess recall bias in favor
of reporting remission of symptoms. We also did not consider
medication treatment in our analyses and medications might
potentially influence course of symptoms. Nevertheless, this study
included the largest sample size to date that specifically investigated the
natural course of TS and particularly comorbid ADHD and OCD and
despite potential limitations provides new and important information.
Our study confirms previously reported data regarding the natural
course of TS and provides new information about reported tic
remission and the course of the common comorbidities ADHD and
OCD. Until more objective, larger scale, and prospective research on
the temporal course of TS can be completed, this data on the natural
course of the TS triad can inform the design of experimental
therapeutic trials aimed at improving the rate or time frame of
remission of the illness.
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